Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)
Lung Cancer Update
00:00
Is There a KRS Inhibitor in Colorectal Cancer?
I would think Osmurtable will still be effective. It's not really clear why, because T7NNNN shouldn't impact the efficacy of the patients. Justin, any questions about targeted therapy before we start moving into immunotherapy? Do you ever combine that with Satuximab? And the second question is about taking PPI's with those medications. Most patients are on them, and how does that affect absorption?
Transcript
Play full episode
